Objective To establish the methods of cytokine-induced killer( CIK) cells and evaluate the characteristics,anti-tumor activity in vitro and in vivo and the safety. Methods Anti-CD3 mAb,recombinant human interleukin2( rhIL-2) and recombinant human interferon-γ( rhIFN-γ) were used to induce the peripheral blood mononuclear cells( PBMCs) proliferation abundantly in vitro. Flow cytometry assay( FACS),in vitro cytotoxicity assay and tumor mouse model xenografted with Ho-8910( human ovarian cancer cell line) were used to detect the characteristics and the anti-tumor activityof CIK cells. Additionally,the contamination of exogenous agents and the acute toxicity effect of CIK cells were also determined. Results After 21 days in vitro culture,the total number of CIK cells were more than 1010,among which there were mainly CD3+CD8+T cells and CD3+CD56+NKT cells. CIK cells displayed high cytotoxicity against Ho8910,A549,K562 and HepG2 cells in vitro,and they also showed therapeutic effects in tumor xenografted mice. Additionally,no acute toxicity was observed in CIK cells-treated mice,and there was also no contamination of bacteria,fungus,mycoplasma and virus in CIK cells. Conclusion CIK cells have high antitumor activity without any toxic side effects.